Detailed Information

Cited 0 time in webofscience Cited 1 time in scopus
Metadata Downloads

Cognitive decline according to amyloid uptake in patients with poststroke cognitive impairment

Full metadata record
DC Field Value Language
dc.contributor.authorYoon, Bora-
dc.contributor.authorYang, Dong Won-
dc.contributor.authorHong, Yun-Jeong-
dc.contributor.authorKim, Taewon-
dc.contributor.authorNa, Seunghee-
dc.contributor.authorNoh, Sang-Mi-
dc.contributor.authorPark, Hye Lim-
dc.contributor.authorKu, Bon D.-
dc.contributor.authorYang, Young Soon-
dc.contributor.authorChoi, Hojin-
dc.contributor.authorJang, Jae-Won-
dc.contributor.authorKim, Seongheon-
dc.contributor.authorKim, Yerim-
dc.contributor.authorShim, YongSoo-
dc.date.accessioned2022-07-06T14:32:55Z-
dc.date.available2022-07-06T14:32:55Z-
dc.date.created2021-11-22-
dc.date.issued2021-09-
dc.identifier.issn0025-7974-
dc.identifier.urihttps://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/141091-
dc.description.abstractBackground and purpose: Poststroke cognitive impairment (PSCI) is common, but the impact of beta-amyloid (A beta) on PSCI is uncertain. The proposed study will investigate amyloid pathology in participants with PSCI and how differently their cognition progress according to the amyloid pathology. Methods: This multicenter study was designed to be prospective and observational based on a projected cohort size of 196 participants with either newly developed cognitive impairment, or rapidly aggravated CI, within 3 months after acute cerebral infarction. They will undergo F-18-flutemetamol positron emission tomography at baseline and will be categorized as either amyloid-positive (A+) or amyloid-negative (A-) by visual rating. The primary outcome measures will be based on Korean Mini-Mental State Examination changes (baseline to 12 months) between the A+ and A- groups. The secondary outcome measures will be the dementia-conversion rate and changes in the Korean version of the Montreal Cognitive Assessment (baseline to 12 months) between the A+ and A- groups. Conclusions: This study will provide a broadened perspective on the impact of A beta on the cause and outcomes of PSCI in clinical practice. Identifying amyloid pathology in patients with PSCI will help select patients who need more focused treatments such as acetylcholinesterase inhibitors-
dc.language영어-
dc.language.isoen-
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-
dc.titleCognitive decline according to amyloid uptake in patients with poststroke cognitive impairment-
dc.typeArticle-
dc.contributor.affiliatedAuthorChoi, Hojin-
dc.identifier.doi10.1097/MD.0000000000027252-
dc.identifier.scopusid2-s2.0-85117537816-
dc.identifier.wosid000697773400030-
dc.identifier.bibliographicCitationMEDICINE, v.100, no.38, pp.1 - 5-
dc.relation.isPartOfMEDICINE-
dc.citation.titleMEDICINE-
dc.citation.volume100-
dc.citation.number38-
dc.citation.startPage1-
dc.citation.endPage5-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaGeneral & Internal Medicine-
dc.relation.journalWebOfScienceCategoryMedicine, General & Internal-
dc.subject.keywordPlusKOREAN VERSION-
dc.subject.keywordPlusBETA-
dc.subject.keywordPlusSTROKE-
dc.subject.keywordPlusVALIDATION-
dc.subject.keywordAuthoramyloid-
dc.subject.keywordAuthorcerebral infarct-
dc.subject.keywordAuthorclinical trial-
dc.subject.keywordAuthorcognitive impairment-
dc.subject.keywordAuthorprognosis-
Files in This Item
Appears in
Collections
서울 의과대학 > 서울 신경과학교실 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Choi, Hojin photo

Choi, Hojin
COLLEGE OF MEDICINE (DEPARTMENT OF NEUROLOGY)
Read more

Altmetrics

Total Views & Downloads

BROWSE